A detailed history of Verition Fund Management LLC transactions in Insmed Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 15,821 shares of INSM stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,821
Holding current value
$1.06 Million
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $348,062 - $1.1 Million
15,821 New
15,821 $1.06 Million
Q4 2023

Feb 14, 2024

SELL
$23.42 - $31.74 $152,253 - $206,341
-6,501 Reduced 38.93%
10,199 $316,000
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $50,166 - $68,025
2,526 Added 17.82%
16,700 $421,000
Q2 2023

Aug 14, 2023

SELL
$16.44 - $21.1 $217,221 - $278,794
-13,213 Reduced 48.25%
14,174 $299,000
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $445,312 - $595,119
27,387 New
27,387 $466,000
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $852,780 - $1.15 Million
40,842 New
40,842 $880,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.